Please join President & CEO Vasu Rangadass, Ph.D. for an in-depth look at the future of the lab and the digitalization of cell and gene therapy space. This session will also explore L7’s work with Gradalis, a late-stage biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer.
To access this resource, please make sure to accept cookies. The resource will only be visible after submitting the form if cookies have been accepted.